Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.20 -0.02 (-8.00%)
As of: Oct 22, 2026 · 10:35 AM EDT

Senti Biosciences Holdings (SNTI) Capital Leases (2023)

Updated

Senti Biosciences Holdings (SNTI) posted Capital Leases of $25,000 for Q3 2023, down 49.0% from the prior quarter.

Analysis

Senti Biosciences Holdings (SNTI) Capital Leases (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.12 Bn 1,134.70 Bn 19.71 Bn
2 Johnson & Johnson 634.67 Bn 553.20 Bn 17.26 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn
4 Merck 377.66 Bn 332.04 Bn 12.21 Bn
5 Novartis Ag 303.82 Bn 267.81 Bn 11.24 Bn
6 Astrazeneca 266.80 Bn 240.49 Bn 12.86 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn
9 Pfizer 172.20 Bn 118.84 Bn 10.94 Bn
10 Senti Biosciences Holdings 6.23 Mn -50.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 25,000.00
Jun 30, 2023 49,000.00
Mar 31, 2023 73,000.00
API Access

Senti Biosciences Holdings Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=SNTI&period=max&api_key=YOUR_API_KEY